Identification of c-Met as a novel target of γ-glutamylcyclotransferase
Abstract γ-Glutamylcyclotransferase (GGCT) is highly expressed in multiple types of cancer tissues and its knockdown suppresses the growth of cancer cells in vitro and in vivo. Although GGCT is a promising target for cancer therapy, the mechanisms underlying the antitumor effects remain unclear. The...
Main Authors: | Yumiko Saito, Keiko Taniguchi, Hiromi Ii, Mano Horinaka, Susumu Kageyama, Susumu Nakata, Osamu Ukimura, Toshiyuki Sakai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-39093-7 |
Similar Items
-
Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
by: Ryoichi Tanaka, et al.
Published: (2015-01-01) -
The dual RAF/MEK inhibitor CH5126766/RO5126766 may be a potential therapy for RAS-mutated tumor cells.
by: Makoto Wada, et al.
Published: (2014-01-01) -
Somatic mutations in IFN-γ-Signal molecules in human uterine leiomyosarcoma
by: Tonegawa, Susumu
Published: (2020) -
A Cortisol-Secreting Adrenal Adenoma Combined With a Micro-Pheochromocytoma: Case Report and Literature Review
by: Kimiko Sakai, et al.
Published: (2023-01-01) -
Discovery of cancer-preventive juices reactivating RB functions
by: Mitsuharu Masuda, et al.
Published: (2023-09-01)